#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Polyneuropathy Plasma cell myeloma refractory ROHHAD syndrome Desmoid tumour Oesophageal adenocarcinoma stage III Neurotrophic keratopathy Severe myoclonic epilepsy of infancy Transitional cell carcinoma Drug eruption Prader-Willi syndrome Chronic lymphocytic leukaemia Follicle centre lymphoma follicular grade I II – III refractory Bronchiectasis Neuroendocrine carcinoma of the skin Erdheim-Chester disease More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis Glomerulonephritis membranoproliferative – Life with Disease Lysosomal storage disorder – Diagnostics Phenylketonuria – Diagnostics Wolfram syndrome – Life with Disease Erdheim-Chester disease – Life with Disease Toxic epidermal necrolysis – Life with Disease Hereditary hypophosphataemic rickets – Diagnostics Optic glioma – Treatment Amyotrophic lateral sclerosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Fibrinogen ZALFERMIN Exl01 Gimeracil Riboflavin Sodium Phosphate Oms906 Artemisia Vulgaris Gsk3739937 Glycine Ferric Derisomaltose Tetracaine Hydrochloride Triamcinolone Acetonide Pitolisant Imipramine Hydrochloride Ag13909 Bi 1839100 Pervi-Fus Human Von Willebrand Factor Reparixin Omeprazole More therapies…

    Learn about Your Condition

    Haemoptysis Frostbite Pancreatic carcinoma Hip fracture Hypertriglyceridaemia Acquired haemophilia Adenovirus infection Idiopathic pulmonary fibrosis Merycism Head and neck cancer stage III Tuberculosis Barrett's oesophagus Sickle cell anaemia Liver transplant rejection Benign prostatic hyperplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. ICMR (International Center for Medical Research)

ICMR (International Center for Medical Research)

Calle De Cinca 21, Madrid, 28002, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    France Germany Hungary Italy Poland Spain

  • Study on Botulinum Toxin Type A for Reducing Jaw Muscle Size in Adults with Prominent Masseter Muscle

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium Bulgaria France Germany Italy The Netherlands +1

  • Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Agents For Dermatitis, Excluding Corticosteroids
    • Corticosteroids, Potent (Group Iii)
    • Corticosteroids, Very Potent (Group Iv)
    Czechia France Germany Poland Spain
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!